Concepedia

Edward L. Engelhardt

EL

Statistics

Publications

32

Citations

879

H-Index

19

Active since

1944

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Fox Chase Cancer Center

Edward L. Engelhardt is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and natural sciences.

Top concepts

PharmacologyMedicineOrganic ChemistryDrug DiscoveryNatural SciencesMedicinal ChemistryChemistryBiochemistryPharmacotherapyEngineering

Publications per year

1944–2002

32

Publications

32

Cyclization-activated prodrugs. Basic carbamates of 4-hydroxyanisole

Walfred S. Saari, J. E. SCHWERING, Paulette A. Lyle et al. · Journal of Medicinal Chemistry · 1990 · 101 citations

Medicinal Chemistry, Pharmaceutical Science, Bioorganic Chemistry +13

Heterocyclic analogs of the antihypertensive .beta.-adrenergic blocking agent (S)-2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridine

John J. Baldwin, Edward L. Engelhardt, Ralph Hirschmann et al. · Journal of Medicinal Chemistry · 1980 · 76 citations

Molecular Pharmacology, Medicinal Chemistry, Hypertension +14

Synthesis and antihypertensive activity of some ester progenitors of methyldopa

Walfred S. Saari, Mark B. Freedman, Richard D. Hartman et al. · Journal of Medicinal Chemistry · 1978 · 52 citations

Structure-Activity Relationships in the Cyproheptadine Series

Edward L. Engelhardt, Howard C. Zell, Walfred S. Saari et al. · Journal of Medicinal Chemistry · 1965 · 47 citations

Pharmaceutical Science, Altmetric Attention Score, Pharmacotherapy +21

Ketene Acetals. XIV. The Reactions of Ketene Acetal with Quinones

S. M. McElvain, Edward L. Engelhardt · Journal of the American Chemical Society · 1944 · 43 citations

Halogenation, Chemical Measurement, Engineering +14

1–5 of 32